Another prominent medication release mechanism simply by acoustics and it is well confirmed simply by acoustically active liposomes (AAL)
Another prominent medication release mechanism simply by acoustics and it is well confirmed simply by acoustically active liposomes (AAL). / clinicalSolid tumors[13,14,15] Docetaxel prodrugMM-310Egg produced sphingomyelin/ br / CHActive (Anti-Ephrin receptor A2)IV, in vivo, br / clinicalSolid tumors[16,17,18,19]DOXC225-ILs-dox DSPC/CH/mPEG-DSPEActive (Anti-EGFR Fab fragment from mAb C225 (cetuximab))IV, in vivo, br / clinicalGlioblastoma[15,19,20,21] DOXMM-302HSPC/CH/DSPE-PEGActive (Anti-HER2 antibody)IV, in vivo, br / clinicalBreast tumor[22,23]Melanoma antigens + interferon-gammaLipovaxin-MM POPC/Ni-3NTA-DTDAActive (One area antibody (dAb) fragment (VH))IV, in vivo, br / clinicalMalignant melanoma[15,24]RB94 plasmid DNASGT-94DOTAP/DOPEActive (Anti-Transferrin Antibody fragment (scFv))IV, in vivo, br / clinicalSolid tumor[15,25,26,27]DOX2B3-101HSPC/CH/DSPE-PEG Energetic (Glutathione ligand) IV, in vivo, br / clinicalActive human brain metastasis, meningeal carcinomatosis[18,28,29]Tetrandrine + vincristine-EPC/CH/DSPE-PEG 2000Active (Transferrin ligand)IV, in vivo in miceBrain glioma[19,30]Bleomycin-DOPE/CHActive (Folic acidity ligand)In vitroCervical and breasts cancers cell lines[19,31]DOX-DOPE/DOPC/LecithinActive (Glycoprotein ligand)IV, in vivo in miceMouse melanoma cells[32]ATRA -DPPC/CH/DSPE-mPEG2000PassiveIn vitroHuman thyroid carcinoma cell lines[33]ATRA -DOTAP/CHPassiveIn vivo in mice, IVLung tumor[34]Daunorubicin?+? br / Cytarabine VYXEOSDSPG/DSPC/CHPassiveIV, in vivo, FDA approvedSecondary severe…